Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection

British Journal of Cancer

Volumn 106, Issue 5, 2012, Pages 909-915

  Nunes, J ^a   Naymark, M ^a   Sauer, L ^a   Muhammad, A ^a   Keun, H ^a   Sturge, J ^a   Stebbing, J ^a   Waxman, J ^a   Pchejetski, D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

anaemia; diagnosis; molecular marker; prognosis; prostate cancer; sphingosine 1 phosphate

Indexed keywords

BIOLOGICAL MARKER; PROSTATE SPECIFIC ANTIGEN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE 1;

ARTICLE; BLOOD LEVEL; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROSTATE CANCER;

ANEMIA; CELL LINE, TUMOR; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; ERYTHROCYTES; HUMANS; LYSOPHOSPHOLIPIDS; MALE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SPHINGOSINE; TUMOR MARKERS, BIOLOGICAL;

EID: 84857787578     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.14     Document Type: Article

References (32)

1. ACS (2011) American Cancer Society, http://www.cancer.org/Research/ CancerFactsFigures/index
2. Bielawski J, Szulc ZM, Hannun YA, Bielawska A (2006) Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 39(2): 82-91 (Pubitemid 44107706)
3. Bonhoure E, Pchejetski D, Aouali N, Morjani H, Levade T, Kohama T, Cuvillier O (2006) Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting sphingosine kinase-1. Leukemia 20(1): 95-102
4. Camerer E, Regard JB, Cornelissen I, Srinivasan Y, Duong DN, Palmer D, Pham TH, Wong JS, Pappu R, Coughlin SR (2009) Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammationinduced vascular leak in mice. J Clin Invest 119(7): 1871-1879
5. Deutschman DH, Carstens JS, Klepper RL, Smith WS, Page MT, Young TR, Gleason LA, Nakajima N, Sabbadini RA (2003) Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am Heart J 146(1): 62-68 (Pubitemid 36851301)
6. Eberhard M, Ferlinz K, Alizzi K, Cacciato PM, Faggio C, Foller M, Lang F (2010) FTY720-induced suicidal erythrocyte death. Cell Physiol Biochem 26(4-5): 761-766
7. Edsall LC, Spiegel S (1999) Enzymatic measurement of sphingosine 1-phosphate. Anal Biochem 272(1): 80-86 (Pubitemid 29343385)
8. Fox TE, Bewley MC, Unrath KA, Pedersen MM, Anderson RE, Jung DY, Jefferson LS, Kim JK, Bronson SK, Flanagan JM, Kester M (2011) Circulating sphingolipid biomarkers in models of type 1 diabetes. J Lipid Res 52(3): 509-517
9. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR, English D (2001) Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 108(5): 689-701 (Pubitemid 32906197)
10. Hanel P, Andreani P, Graler MH (2007) Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 21(4): 1202-1209 (Pubitemid 46495709)
11. Henry NL, Pchejetski D, A'Hern R, Nguyen AT, Charles P, Waxman J, Li L, Storniolo AM, Hayes DF, Flockhart DA, Stearns V, Stebbing J (2010) Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study. Br J Cancer 103(3): 291-296
12. Iversen P, Rasmussen F, Christensen IJ (1994) Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma. Scand J Urol Nephrol 157: 41-47 (Pubitemid 24205646)
13. Kawamori T, Osta W, Johnson KR, Pettus BJ, Bielawski J, Tanaka T, Wargovich MJ, Reddy BS, Hannun YA, Obeid LM, Zhou D (2006) Sphingosine kinase 1 is up-regulated in colon carcinogenesis. FASEB J 20(2): 386-388 (Pubitemid 46671180)
14. Licht T, Tsirulnikov L, Reuveni H, Yarnitzky T, Ben-Sasson SA (2003) Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3). Blood 102(6): 2099-2107 (Pubitemid 37122386)
15. Lin DW (2009) Beyond PSA: utility of novel tumor markers in the setting of elevated PSA. Urol Oncol 27(3): 315-321
16. Malavaud B, Pchejetski D, Mazerolles C, de Paiva GR, Calvet C, Doumerc N, Pitson S, Rischmann P, Cuvillier O (2010) Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens. Eur J Cancer 46(18): 3417-3424
17. Nelius T, Filleur S (2009) PSA surge/flare-up in patients with castrationrefractory prostate cancer during the initial phase of chemotherapy. Prostate 69(16): 1802-1807
18. Ohkawa R, Nakamura K, Okubo S, Hosogaya S, Ozaki Y, Tozuka M, Osima N, Yokota H, Ikeda H, Yatomi Y (2008) Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters. Ann Clin Biochem 45(Pt 4): 356-363 (Pubitemid 352031541)
19. Olivera A, Kohama T, Edsall L, Nava V, Cuvillier O, Poulton S, Spiegel S (1999) Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival. J Cell Biol 147(3): 545-558
20. Pchejetski D, Bohler T, Brizuela L, Sauer L, Doumerc N, Golzio M, Salunkhe V, Teissie J, Malavaud B, Waxman J, Cuvillier O (2010a) FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1. Cancer Res 70(21): 8651-8661
21. Pchejetski D, Doumerc N, Golzio M, Naymark M, Teissie J, Kohama T, Waxman J, Malavaud B, Cuvillier O (2008) Chemosensitizing effects of sphingosine kinase-1 inhibition in prostate cancer cell and animal models. Mol Cancer Ther 7(7): 1836-1845
22. Pchejetski D, Golzio M, Bonhoure E, Calvet C, Doumerc N, Garcia V, Mazerolles C, Rischmann P, Teissie J, Malavaud B, Cuvillier O (2005) Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res 65(24): 11667-11675 (Pubitemid 41821727)
23. Pchejetski D, Nunes J, Sauer L, Sidhu J, Sharma A, Keun HC, Waxman J, Stebbing J (2010b) Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer. Breast Cancer Res Treat 124(2): 543-549
24. Rodriguez C, Gonzalez-Diez M, Badimon L, Martinez-Gonzalez J (2009) Sphingosine-1-phosphate: A bioactive lipid that confers high-density lipoprotein with vasculoprotection mediated by nitric oxide and prostacyclin. Thromb Haemost 101(4): 665-673
25. Ruckhaberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, Grosch S, Geisslinger G, Holtrich U, Karn T, Kaufmann M (2008) Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat 112(1): 41-52
26. Sauer L, Nunes J, Salunkhe V, Skalska L, Kohama T, Cuvillier O, Waxman J, Pchejetski D (2009) Sphingosine kinase 1 inhibition sensitizes hormoneresistant prostate cancer to docetaxel. Int J Cancer 125(11): 2728-2736
27. Sutphen R, Xu Y, Wilbanks GD, Fiorica J, Grendys Jr EC, LaPolla JP, Arango H, Hoffman MS, Martino M, Wakeley K, Griffin D, Blanco RW, Cantor AB, Xiao YJ, Krischer JP (2004) Lysophospholipids are potential biomarkers of ovarian cancer. Cancer Epidemiol Biomarkers Prev 13(7): 1185-1191 (Pubitemid 38917907)
28. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman Jr CA (2004) Prevalence of prostate cancer among men with a prostatespecific antigen level. N Engl J Med 350(22): 2239-2246
29. Van Hemelrijck M, Garmo H, Holmberg L, Ingelsson E, Bratt O, Bill-Axelson A, Lambe M, Stattin P, Adolfsson J (2010) Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the population-based PCBaSe Sweden. J Clin Oncol 28(21): 3448-3456
30. Venkataraman K, Lee YM, Michaud J, Thangada S, Ai Y, Bonkovsky HL, Parikh NS, Habrukowich C, Hla T (2008) Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 102(6): 669-676 (Pubitemid 351457860)
31. Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, Matteo RG, Garland WA, Lu Y, Yu S, Hall HS, Kundra V, Mills GB, Sabbadini RA (2006) Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9(3): 225-238 (Pubitemid 43357948)
32. Xia P, Gamble JR, Wang L, Pitson SM, Moretti PA, Wattenberg BW, D'Andrea RJ, Vadas MA (2000) An oncogenic role of sphingosine kinase. Curr Biol 10(23): 1527-1530 (Pubitemid 32003646)